Translational Development Acquisition (TDACU) Competitors $10.27 -0.09 (-0.87%) As of 03:39 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock TDACU vs. ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, and AITRUShould you be buying Translational Development Acquisition stock or one of its competitors? The main competitors of Translational Development Acquisition include A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), and AI Transportation Acquisition (AITRU). These companies are all part of the "trading" industry. Translational Development Acquisition vs. A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition A SPAC III Acquisition (NASDAQ:ASPCU) and Translational Development Acquisition (NASDAQ:TDACU) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk. Is ASPCU or TDACU more profitable? Company Net Margins Return on Equity Return on Assets A SPAC III AcquisitionN/A N/A N/A Translational Development Acquisition N/A N/A N/A Does the MarketBeat Community believe in ASPCU or TDACU? A SPAC III Acquisition and Translational Development Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformA SPAC III AcquisitionN/AN/ATranslational Development AcquisitionN/AN/A Which has stronger earnings and valuation, ASPCU or TDACU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioA SPAC III AcquisitionN/AN/AN/AN/AN/ATranslational Development Acquisition$5.64MN/AN/AN/AN/A Does the media prefer ASPCU or TDACU? In the previous week, A SPAC III Acquisition and A SPAC III Acquisition both had 1 articles in the media. Translational Development Acquisition's average media sentiment score of 1.89 beat A SPAC III Acquisition's score of 1.87 indicating that Translational Development Acquisition is being referred to more favorably in the news media. Company Overall Sentiment A SPAC III Acquisition Very Positive Translational Development Acquisition Very Positive SummaryTranslational Development Acquisition beats A SPAC III Acquisition on 2 of the 2 factors compared between the two stocks. Get Translational Development Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TDACU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TDACU vs. The Competition Export to ExcelMetricTranslational Development AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$191.52M$11.53B$8.46BDividend YieldN/AN/A5.54%4.18%P/E RatioN/AN/A22.5719.78Price / SalesN/AN/A26.57138.44Price / CashN/AN/A17.6234.64Price / BookN/AN/A2.794.54Net IncomeN/AN/A$1.03B$247.85M7 Day PerformanceN/A-0.25%0.50%1.68%1 Month Performance0.69%1.70%3.77%8.76%1 Year PerformanceN/A37.12%538.77%9.69% Translational Development Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TDACUTranslational Development AcquisitionN/A$10.27-0.9%N/AN/A$0.00$5.64M0.00N/APositive NewsASPCUA SPAC III AcquisitionN/A$10.31+0.2%N/AN/A$0.00N/A0.00N/AAGBAWAGBA GroupN/A$0.09-4.9%N/A-54.3%$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$24.96-0.2%N/A+4.3%$0.00$584M0.0050Short Interest ↑AGNCOAGNC InvestmentN/A$25.43-0.2%N/A+2.4%$0.00$584M0.0050Short Interest ↑AGNCNAGNC InvestmentN/A$25.76+0.3%N/A-0.5%$0.00$584M0.0050Short Interest ↓AGNCMAGNC InvestmentN/A$24.73+0.1%N/A-1.9%$0.00$584M0.0050AGNCLAGNC InvestmentN/A$25.25-0.1%N/A+4.1%$0.00$584M0.0050Positive NewsShort Interest ↑ANSCWAgriculture & Natural Solutions AcquisitionN/A$0.20+4.3%N/A-5.3%$0.00N/A0.00N/AGap DownANSCUAgriculture & Natural Solutions AcquisitionN/A$10.75flatN/A+3.2%$0.00N/A0.00N/AAITRUAI Transportation AcquisitionN/A$11.24flatN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies ASPCU Competitors AGBAW Competitors AGNCP Competitors AGNCO Competitors AGNCN Competitors AGNCM Competitors AGNCL Competitors ANSCW Competitors ANSCU Competitors AITRU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TDACU) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredThe biggest threat isn’t ChinaWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Translational Development Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Translational Development Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
